Ashley Walther, Greg Tiao – 30 October 2013 – Watch a video presentation of this article

Valérie A. McLin – 30 October 2013 – Watch a video presentation of this article

Tamir Miloh, Pinar Bulut – 30 October 2013 – Watch a video presentation of this article

Ulrich Beuers, Andreas E. Kremer, Ruth Bolier, Ronald P.J. Oude Elferink – 29 October 2013 – Pruritus is a common symptom in patients with cholestatic liver diseases such as primary biliary cirrhosis, primary sclerosing cholangitis, intrahepatic cholestasis of pregnancy, or hereditary pediatric cholestatic disorders and may accompany, although less frequently, many other liver diseases.

Young‐Joo Yang, Ju Hyun Shim, Kang Mo Kim, Young‐Suk Lim, Han Chu Lee – 29 October 2013 – A primary nonresponse to oral drugs against hepatitis B virus (HBV) is a generally accepted criterion for interrupting treatment. We investigated whether the concept of primary nonresponse suggested by current American (AASLD) and European (EASL) guidelines is appropriate for treatment with entecavir (ETV). The study included 1,254 treatment‐naïve patients who had pretreatment HBV DNA levels of >2,000 IU/mL and received ETV 0.5 mg/day for over 6 months.

Chih‐Chi Wang, Salvador Lopez‐Valdes, Ting‐Lung Lin, Anthony Yap, Chee‐Chien Yong, Wei‐Feng Li, Shih‐Ho Wang, Chih‐Che Lin, Yueh‐Wei Liu, Tsan‐Shiun Lin, Allan M. Concejero, Hock‐Liew Eng, Douglas Henry, Yu‐Fan Cheng, Bruno Jawan, Chao‐Long Chen – 29 October 2013 – The outflow reconstruction of the right anterior sector in a right liver graft (RLG) with cryopreserved vascular grafts (CVGs) is crucial for preventing graft congestion in living donor liver transplantation (LDLT). The impact of the duration of cryopreservation has not been evaluated so far.

Juanjuan Zhao, Zheng Zhang, Yan Luan, Zhengsheng Zou, Yanling Sun, Yonggang Li, Lei Jin, Chunbao Zhou, Junliang Fu, Bin Gao, Yangxin Fu, Fu‐Sheng Wang – 29 October 2013 – It is well established that interleukin (IL)‐22 has hepatoprotective and antifibrotic functions in acute liver injury models; however, its function in patients with liver fibrosis and liver cirrhosis (LC) remains obscure.

Ulrich Beuers, Andreas E. Kremer, Ruth Bolier, Ronald P.J. Oude Elferink – 29 October 2013 – Pruritus is a common symptom in patients with cholestatic liver diseases such as primary biliary cirrhosis, primary sclerosing cholangitis, intrahepatic cholestasis of pregnancy, or hereditary pediatric cholestatic disorders and may accompany, although less frequently, many other liver diseases.

Andrea D. Branch, Burc Barin, Adeeb Rahman, Peter Stock, Thomas D. Schiano – 29 October 2013 – An optimal vitamin D status may benefit liver transplantation (LT) patients. Higher levels of 25‐hydroxyvitamin D [25(OH)D] mitigate steroid‐induced bone loss after LT, correlate with better hepatitis C virus treatment responses, and increase graft survival.

Nir I. Nativ, Alvin I. Chen, Gabriel Yarmush, Scot D. Henry, Jay H. Lefkowitch, Kenneth M. Klein, Timothy J. Maguire, Rene Schloss, James V. Guarrera, Francois Berthiaume, Martin L. Yarmush – 29 October 2013 – Large‐droplet macrovesicular steatosis (ld‐MaS) in more than 30% of liver graft hepatocytes is a major risk factor for liver transplantation.